Jiong Shao

China Tech Analyst, Barclays
· tracked since Mar 2026
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 1
Best Calls
No live winners yet
Worst Calls
TCEHY long -11.9%
Most Mentioned
TCEHY ×1
Recent Calls
TCEHY long 2 months ago
Win Rate 0% Long 1 Short 0
Win Rate
7d 0%
30d 100%
90d
Average Return -11.9% Long Return -11.9% Short Return -
Average Return
7d -4.9%
30d +1.2%
90d
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
Long
Mar 19
$66.00
-11.9%
The analyst states Tencent's results were "very strong," beating across the board, but the most interesting thing is its investment in "OpenClaw." He compares this to the WeChat moment 15 years ago, calling it an "equalizer" that allows Tencent to leverage its app development and user connectivity strengths. The OpenClaw agent platform enables Tencent to monetize AI in the enterprise (a leapfrog in China's SaaS) and consumer spaces (via digital agents), driving token demand and subscription fees. The company is best positioned in China to create and market consumer-facing AI apps. The market is mispricing the stock by focusing on near-term margin drag from AI Capex instead of the long-term platform shift. The analyst's price target (~$100 USD) implies significant upside from current levels. Failure to successfully commercialize the OpenClaw platform and agents; stronger-than-expected competition eroding monetization potential.
The analyst states Tencent's results were "very strong," beating across the board, but the most interesting thing is its investment in "OpenClaw." He compares this to the WeChat moment 15 years ago, calling it an "equalizer" that allows Tencent to leverage its app development and user connectivity strengths. The OpenClaw agent platform enables Tencent to monetize AI in the enterprise (a leapfrog in China's SaaS) and consumer spaces (via digital agents), driving token demand and subscription fees. The company is best positioned in China to create and market consumer-facing AI apps. The market is mispricing the stock by focusing on near-term margin drag from AI Capex instead of the long-term platform shift. The analyst's price target (~$100 USD) implies significant upside from current levels. Failure to successfully commercialize the OpenClaw platform and agents; stronger-than-expected competition eroding monetization potential.
AI/Semi
Showing 1 of 1 picks ยท sorted by mentions